Literature DB >> 12062496

The influence of medium-chain triglycerides on the stability of all-in-one formulations.

David F Driscoll1, Jorg Nehne, Horst Peterss, Rolf Franke, Bruce R Bistrian, Wilhelm Niemann.   

Abstract

When mixed with parenteral nutrients as an all-in-one admixture, previous data have demonstrated that lipid emulsions composed of medium-chain triglycerides (MCTs) and long-chain triglycerides (LCTs) yield more stable formulations compared with those compounded with pure LCT lipid emulsions. We investigated the physical stability of various preparations of intravenous lipid emulsions as all-in-one admixtures. Each final lipid emulsion used to compound the all-in-one formulation was a 20% w/v mixture containing MCTs and LCTs as either a single emulsion containing both triglycerides, or an emulsion made extemporaneously from separate starting emulsions of pure MCT and LCT. The first emulsion was composed of a 50:50 (by weight) physical mixture of MCTs and LCTs, and consisted of 50% MCT:40% omega-6 LCT (soybean oil):10% omega-3 LCT (fish oil) that was available as a single 20% w/v lipid emulsion. The second and third emulsions were specially prepared from separate stock dispersions containing pure 20% w/v MCT and pure 20% w/v LCT (soybean oil) lipid emulsions, and were made in volume ratios of 75% MCT:25% omega-6 LCT and 50% MCT:50% omega-6 LCT, respectively. This was done in order to investigate whether the method of emulsion preparation and/or ratio of MCT to LCT influenced all-in-one admixture stability. Each all-in-one admixture was studied at four intervals over 30 h at room temperature conditions by light extinction (or obscuration) using a single-particle optical sensing (LE/SPOS) technique. The data, performed in duplicate at each interval, is expressed as the volume-weighted percent of fat (PFAT) globules >5 microm. The results confirm the stabilizing effects of MCTs when made as a physical oil mixture as a single lipid emulsion. However, stabilization is lost if the MCT and LCT emulsions are mixed from separate starting emulsions and then compounded as an all-in-one formulation. The extemporaneous mixing of commercial lipid emulsions is not recommended.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062496     DOI: 10.1016/s0378-5173(02)00036-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

Review 1.  Lipid injectable emulsions: Pharmacopeial and safety issues.

Authors:  David F Driscoll
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

Review 2.  Intravenous Lipid Emulsions in Parenteral Nutrition.

Authors:  Gillian L Fell; Prathima Nandivada; Kathleen M Gura; Mark Puder
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

3.  Evaluation of self-emulsified DIM-14 in dogs for oral bioavailability and in Nu/nu mice bearing stem cell lung tumor models for anticancer activity.

Authors:  Apurva R Patel; Ravi Doddapaneni; Terrick Andey; Heather Wilson; Stephen Safe; Mandip Singh
Journal:  J Control Release       Date:  2015-06-14       Impact factor: 9.776

Review 4.  Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient: Understanding the Differences.

Authors:  Lorenzo Anez-Bustillos; Duy T Dao; Meredith A Baker; Gillian L Fell; Mark Puder; Kathleen M Gura
Journal:  Nutr Clin Pract       Date:  2016-08-16       Impact factor: 3.080

5.  Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity.

Authors:  Apurva R Patel; Chandraiah Godugu; Heather Wilson; Stephen Safe; Mandip Singh
Journal:  Pharm Res       Date:  2015-01-10       Impact factor: 4.200

6.  Tracking of the kinetic stability of 2 types of total nutrient admixtures containing different lipid emulsions.

Authors:  Judit Balogh; Dorottya Kiss; Judit Dredán; István Puskás; Ferenc Csempesz; Romána Zelkó
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

7.  Physical compatibility of MCT/LCT propofol emulsions with crystalloids during simulated Y-site administration.

Authors:  Gábor Szalai; Gábor Katona; Mária Matuz; Orsolya Jójárt-Laczkovich; Péter Doró
Journal:  Eur J Hosp Pharm       Date:  2018-01-18

8.  Influence of the relative composition of trace elements and vitamins in physicochemical stability of total parenteral nutrition formulations for neonatal use.

Authors:  Bianca W Lobo; Venício F da Veiga; Lúcio M Cabral; Ricardo C Michel; Nádia M Volpato; Valéria P de Sousa
Journal:  Nutr J       Date:  2012-04-17       Impact factor: 3.271

9.  Potentially Important Therapeutic Interactions between Antibiotics, and a Specially Engineered Emulsion Drug Vehicle Containing Krill-Oil-Based Phospholipids and Omega-3 Fatty Acids.

Authors:  David F Driscoll
Journal:  Antibiotics (Basel)       Date:  2018-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.